Goldberg Mark Alan
Related Filers (7)
- ImmunoGen, Inc. (52)
- SYNAGEVA BIOPHARMA CORP (19)
- IDERA PHARMACEUTICALS, INC. (18)
- Blueprint Medicines Corp (17)
- GLYCOMIMETICS INC (14)
- aTYR PHARMA INC (5)
- Audentes Therapeutics, Inc. (5)
- Show More ...
Ownership (129)
4
Monday, 2/12/2024
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/2/2024
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/1/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 10/2/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/22/2023
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/4/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/5/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/30/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Monday, 6/27/2022
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 4/20/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/7/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/1/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/17/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/10/2021
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 4/5/2021
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 4/2/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/6/2021
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/28/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/22/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/15/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 12/3/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/21/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 10/9/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Monday, 10/5/2020
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/1/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 6/18/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/27/2020
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/19/2020
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 4/3/2020
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/2/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/15/2020
Audentes Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/2/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/2/2019
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/1/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/24/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/20/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 6/6/2019
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/21/2019
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 4/1/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/8/2019
Audentes Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/2/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 12/20/2018
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/7/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 10/1/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 7/2/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/25/2018
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 6/22/2018
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/22/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/8/2018
Audentes Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/21/2018
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 4/2/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2018
Audentes Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/13/2017
Audentes Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/3/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2017
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2017
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/11/2017
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 12/15/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/13/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 10/3/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/6/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/27/2016
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2016
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/26/2016
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/19/2016
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 3/7/2016
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/29/2016
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Thursday, 11/12/2015
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/11/2015
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 7/10/2015
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/1/2015
Blueprint Medicines Corp: Initial statement of beneficial ownership of securities
4
Wednesday, 6/10/2015
IDERA PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/6/2015
aTYR PHARMA INC: Initial statement of beneficial ownership of securities
4
Wednesday, 11/12/2014
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities